Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06346483 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 1 of 3 entries
  2. Primary completion pushed from Apr 30, 2026 to Aug 30, 2026
    • Study completion pushed from Jun 9, 2026 to Sep 30, 2026
    v5
  3. Primary completion date: Sep 9, 2025 to Apr 30, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  4. Primary completion date: Jun 9, 2025 to Sep 9, 2025v3
  5. Primary completion date: Jun 9, 2024 to Jun 9, 2025
    • Study completion date: Jun 9, 2025 to Jun 9, 2026
    • Interventions: Dusting (Procedure) to Dusting with Moses 2.0 Modulation (Procedure), Dusting without Moses 2.0 Modulation (Procedure), Moses 2.0 Modulation (Other)
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates. Currently Moses 2.0 laser technology is FDA approved and currently used in practice since 2021. No study to this date has compared Moses 2.0 without pulse modulation laser technology to Moses 2.0 with pulse modulation laser technology. The study will be including kidney and ureteral stones (a kidney stone located in the tube between the kidney and the bladder) that are 6mm and greater, but less than 20 mm in size undergoing ureteroscopic treatment. High powered lasers are used for "dusting". Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Trial Details
NCT Number NCT06346483
Lead Sponsor Northwestern University
Collaborators: Ohio State University
Conditions
(from sponsor)		 Kidney Stone, Ureteral Stone
Related terms Kidney Calculi, Ureterolithiasis
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov